Effects of Chemotherapy Clinical Trial
Official title:
A Prospective,Randomized,Controlled,Multicenter,Phase III Study of Stage Ⅲ Study of Gemcitabine Plus Cisplatin With or Without Endostatin to the Metastatic Nasopharyngeal Carcinoma
The investigators designed this study to evaluate the efficiency and the acute toxicities of recombinant human endostatin (endostar) combined with chemotherapy in the metastatic nasopharyngeal carcinoma (NPC).
To evaluate the progression free survival (PFS), overall survival (OS), Acute adverse reaction of recombinant human endostatin (endostar) combined with chemotherapy to the metastatic nasopharyngeal carcinoma (NPC). ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05529940 -
NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
|
Phase 3 | |
| Recruiting |
NCT02306837 -
Consolidation Chemotherapy After Autologous Stem Cell Transplantation for Lymphoid Malignancies
|
Phase 2 | |
| Completed |
NCT02771470 -
Intestinal Microflora in Lung Cancer After Chemotherapy
|
Phase 1 | |
| Completed |
NCT02454647 -
Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients
|
N/A | |
| Completed |
NCT02454673 -
Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal Cancer
|
N/A | |
| Completed |
NCT01432223 -
Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab
|
Phase 2 | |
| Completed |
NCT02767388 -
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
|
||
| Recruiting |
NCT02555592 -
Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level
|
N/A | |
| Suspended |
NCT02121405 -
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
|
Phase 3 | |
| Recruiting |
NCT02226380 -
FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer
|
Phase 2 | |
| Completed |
NCT03840824 -
Blood Spot Self-administered Test and Assay
|
||
| Completed |
NCT00911352 -
Cryotherapy Intervention for Docetaxel-induced Nail Toxicities
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT01490060 -
Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
|
N/A | |
| Completed |
NCT02395341 -
The Longitudinal Ovarian Reserve Study
|
N/A | |
| Recruiting |
NCT05268991 -
Aging and Frailty Study
|
||
| Recruiting |
NCT03885388 -
Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6
|
Phase 2/Phase 3 | |
| Completed |
NCT02375776 -
Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention
|
N/A | |
| Enrolling by invitation |
NCT02074241 -
Molecular Markers of Chemosensitivity for Bladder Cancer
|
N/A | |
| Completed |
NCT01143844 -
Assessing Fertility Potential in Female Cancer Survivors
|
||
| Recruiting |
NCT02169388 -
Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy
|
Phase 1 |